Integration of Mendelian Randomization to explore the genetic influences of pediatric sepsis: a focus on RGL4, ATP9A, MAP3K7CL, and DDX11L2

This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis ris...

Full description

Saved in:
Bibliographic Details
Published inBMC pediatrics Vol. 25; no. 1; pp. 66 - 11
Main Authors Zhang, Liuzhao, Chu, Quanwang, Jiang, Shuyue, Shao, Bo
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 27.01.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways. Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance. Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential. RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
AbstractList Objective This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways. Methods Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance. Results Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential. Conclusion RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment. Keywords: Pediatric sepsis, Mendelian Randomization, Differential expression analysis, RGL4, ATP9A, MAP3K7CL, DDX11L2, Immune cell infiltration
ObjectiveThis study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways.MethodsDifferential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes’ roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance.ResultsDifferential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential.ConclusionRGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways. Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance. Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential. RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
Abstract Objective This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways. Methods Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes’ roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance. Results Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential. Conclusion RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways.OBJECTIVEThis study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways.Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance.METHODSDifferential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance.Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential.RESULTSDifferential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential.RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.CONCLUSIONRGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization (MR), differential gene expression analysis, and immune cell infiltration assessment. It explores their potential as biomarkers for sepsis risk and their involvement in immune-related pathways. Differential expression analysis was performed using public datasets to identify genes with significant expression changes between pediatric sepsis patients and healthy controls. MR analysis utilized genome-wide significant SNPs as instrumental variables to assess causal relationships between gene expression and sepsis risk. Bi-directional MR was conducted to assess both forward and reverse causality. FDR correction was applied to adjust for multiple comparisons in MR results. Immune cell infiltration analysis was performed to investigate the genes' roles in immune responses, and findings were validated with independent datasets. ROC curves were constructed to assess predictive performance. Differential expression analysis identified significant changes in RGL4,ATP9A,MAP3K7CL, and DDX11L2. MR analysis revealed causal associations between these genes and sepsis risk, with RGL4 and ATP9A upregulated (inflammatory roles), and MAP3K7CL and DDX11L2 downregulated (protective roles). Bi-directional MR found no significant reverse causality. Immune cell analysis showed associations with key immune cell types, and ROC analysis demonstrated strong predictive potential. RGL4,ATP9A,MAP3K7CL, and DDX11L2 play important roles in pediatric sepsis risk and immune response regulation, offering insights into genetic and immune mechanisms that may inform future sepsis research and treatment.
ArticleNumber 66
Audience Academic
Author Jiang, Shuyue
Zhang, Liuzhao
Chu, Quanwang
Shao, Bo
Author_xml – sequence: 1
  givenname: Liuzhao
  surname: Zhang
  fullname: Zhang, Liuzhao
– sequence: 2
  givenname: Quanwang
  surname: Chu
  fullname: Chu, Quanwang
– sequence: 3
  givenname: Shuyue
  surname: Jiang
  fullname: Jiang, Shuyue
– sequence: 4
  givenname: Bo
  surname: Shao
  fullname: Shao, Bo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39871218$$D View this record in MEDLINE/PubMed
BookMark eNptks9uEzEQxleoiP6BF-CALCEhDtni8e56vVxQlEKJSEWFcuBmOfY4cbWxw3oXUV6Bl8ZpSkkQ8sHWzG--0Yy_0-zIB49Z9hzoOYDgbyIwIeqcsiqnVcnK_PZRdgJlDTkrCzjaex9npzHeUAq1KPmT7LhoRA0MxEn2a-p7XHaqd8GTYMkVeoOtU558Ud6Etfu5S_WB4I9NGzok_QrJEj32ThPnbTug1xi3xRs0TvVdikfcRBffEkVs0ENKJr3LWTki4_l1Mx6Rq_F18amezEYkdSEXF18BZuxp9tiqNuKz-_ssm394P598zGefL6eT8SzXVcn7XCNnQlOjRK2UQq5VZVijLVpsLG2MLmwJypRomgbqIoWRgsU0szWWq-Ism-5kTVA3ctO5tepuZVBO3gVCt5SqS8O1KLFEtahtrWjDSsO5wEqwhlULUA1fCJ603u20NsNijUaj7zvVHogeZrxbyWX4LgHqmjYFJIXX9wpd-DZg7OXaRY1tqzyGIcoCOC05AN2iL_9Bb8LQ-bQqWTAKVVVzUf2llipNkD4opMZ6KyrHglXAGK2KRJ3_h0rH4Nrp5DPrUvyg4NVewQpV269iaIetO-Ih-GJ_JQ-7-OO5BLAdoLsQY4f2AQEqt8aWO2PLZGx5Z2x5W_wGfqTodA
Cites_doi 10.1111/1759-7714.13833
10.3389/fmed.2021.628302
10.1038/s43586-021-00092-5
10.1093/burnst/tkae006
10.1038/s41576-019-0127-1
10.3390/jfb13020036
10.1016/j.jbc.2022.102527
10.1158/2326-6066.CIR-13-0102
10.1016/j.intimp.2020.106454
10.1016/j.jconrel.2021.10.019
10.1242/dev.146621
10.1371/journal.pgen.1009922
10.1080/0886022X.2020.1758722
10.1038/s41598-018-29108-z
10.21203/rs.3.rs-937649/v1
10.1111/imr.12499
10.1214/20-AOS2027
10.3389/fimmu.2021.740359
10.1155/2020/4370983
10.3390/biom11071011
10.1016/bs.ircmb.2020.10.005
10.1128/MMBR.05015-11
10.1016/j.molcel.2020.09.029
10.1016/S2352-4642(24)00140-8
10.1038/s41420-023-01766-7
10.1007/s00134-019-05878-6
10.4161/viru.27045
10.1016/j.intimp.2020.107087
10.1093/jb/mvv029
10.3389/fimmu.2018.02147
10.1111/j.1749-6632.2010.05834.x
10.3389/fimmu.2023.1325020
10.1097/CCM.0000000000005337
10.1111/febs.13353
10.1093/femspd/ftz055
10.21037/atm-22-3307
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12887-025-05424-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database



MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2431
EndPage 11
ExternalDocumentID oai_doaj_org_article_e4eab7f7a0924d668e582925b1a96b86
PMC11770931
A825122053
39871218
10_1186_s12887_025_05424_y
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c546t-ce628c0da87aaae6ca5d29cfefe9f09dc3f41ad4ed99173efee01fe398fdf6a3
IEDL.DBID 7X7
ISSN 1471-2431
IngestDate Wed Aug 27 01:30:23 EDT 2025
Thu Aug 21 18:40:38 EDT 2025
Fri Jul 11 09:51:12 EDT 2025
Fri Jul 25 19:30:59 EDT 2025
Tue Jun 17 21:55:57 EDT 2025
Tue Jun 10 20:53:09 EDT 2025
Thu May 22 21:23:33 EDT 2025
Tue May 06 01:31:33 EDT 2025
Tue Jul 01 01:20:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Immune cell infiltration
Differential expression analysis
MAP3K7CL
Mendelian Randomization
Pediatric sepsis
RGL4
ATP9A
DDX11L2
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c546t-ce628c0da87aaae6ca5d29cfefe9f09dc3f41ad4ed99173efee01fe398fdf6a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3201557685?pq-origsite=%requestingapplication%
PMID 39871218
PQID 3201557685
PQPubID 42847
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_e4eab7f7a0924d668e582925b1a96b86
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11770931
proquest_miscellaneous_3160461101
proquest_journals_3201557685
gale_infotracmisc_A825122053
gale_infotracacademiconefile_A825122053
gale_healthsolutions_A825122053
pubmed_primary_39871218
crossref_primary_10_1186_s12887_025_05424_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-27
PublicationDateYYYYMMDD 2025-01-27
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-27
  day: 27
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pediatrics
PublicationTitleAlternate BMC Pediatr
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References L Evans (5424_CR2) 2021; 49
5424_CR19
Y Teranishi (5424_CR23) 2015; 282
J Wang (5424_CR24) 2018; 8
Z Lin (5424_CR35) 2021; 17
5424_CR16
Y Miyata (5424_CR14) 2022; 298
RS Watson (5424_CR6) 2024; 8
V Kumar (5424_CR9) 2020; 89
M Cao (5424_CR1) 2023; 9
C Nedeva (5424_CR8) 2021; 11
D Zhu (5424_CR17) 2022; 10
AG Randolph (5424_CR4) 2014; 5
MS Kwak (5424_CR32) 2022; 13
I Mellman (5424_CR39) 2013; 1
MJ Delano (5424_CR22) 2016; 274
5424_CR31
T Ye (5424_CR36) 2021; 49
G-L Lin (5424_CR5) 2018; 9
M Jakab (5424_CR26) 2020; 147
S Bao (5424_CR28) 2020; 42
MOF Hanna (5424_CR38) 2019; 77
5424_CR29
SL Weiss (5424_CR3) 2020; 46
LH Apken (5424_CR18) 2021; 361
5424_CR25
L Niu (5424_CR27) 2021; 12
V Tam (5424_CR12) 2019; 20
E Sanderson (5424_CR13) 2022; 2
C Caraballo (5424_CR37) 2019; 92
A Alcaïs (5424_CR11) 2010; 1214
D Jarczak (5424_CR7) 2021; 8
Y Hao (5424_CR34) 2021; 340
L Wang (5424_CR15) 2020; 80
R Shirakawa (5424_CR20) 2015; 157
JR Tisoncik (5424_CR10) 2012; 76
Y Sun (5424_CR33) 2020; 83
5424_CR21
T Zheng (5424_CR30) 2021; 12
References_xml – volume: 12
  start-page: 737
  issue: 6
  year: 2021
  ident: 5424_CR27
  publication-title: Thorac cancer
  doi: 10.1111/1759-7714.13833
– volume: 92
  start-page: 629
  issue: 4
  year: 2019
  ident: 5424_CR37
  publication-title: Yale J Biol Med
– volume: 8
  start-page: 628302
  year: 2021
  ident: 5424_CR7
  publication-title: Front Med
  doi: 10.3389/fmed.2021.628302
– volume: 2
  start-page: 6
  issue: 1
  year: 2022
  ident: 5424_CR13
  publication-title: Nat Reviews Methods Primers
  doi: 10.1038/s43586-021-00092-5
– ident: 5424_CR21
  doi: 10.1093/burnst/tkae006
– volume: 20
  start-page: 467
  issue: 8
  year: 2019
  ident: 5424_CR12
  publication-title: Nat Rev Genet
  doi: 10.1038/s41576-019-0127-1
– volume: 13
  start-page: 36
  issue: 2
  year: 2022
  ident: 5424_CR32
  publication-title: J Funct Biomaterials
  doi: 10.3390/jfb13020036
– volume: 298
  start-page: 102527
  issue: 11
  year: 2022
  ident: 5424_CR14
  publication-title: J Biol Chem
  doi: 10.1016/j.jbc.2022.102527
– volume: 1
  start-page: 145
  issue: 3
  year: 2013
  ident: 5424_CR39
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-13-0102
– volume: 83
  start-page: 106454
  year: 2020
  ident: 5424_CR33
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.106454
– ident: 5424_CR31
– volume: 340
  start-page: 136
  year: 2021
  ident: 5424_CR34
  publication-title: J Controlled Release
  doi: 10.1016/j.jconrel.2021.10.019
– volume: 147
  start-page: dev146621
  issue: 15
  year: 2020
  ident: 5424_CR26
  publication-title: Development
  doi: 10.1242/dev.146621
– volume: 17
  start-page: e1009922
  issue: 11
  year: 2021
  ident: 5424_CR35
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1009922
– volume: 42
  start-page: 437
  issue: 1
  year: 2020
  ident: 5424_CR28
  publication-title: Ren Fail
  doi: 10.1080/0886022X.2020.1758722
– volume: 8
  start-page: 10795
  issue: 1
  year: 2018
  ident: 5424_CR24
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-29108-z
– ident: 5424_CR29
  doi: 10.21203/rs.3.rs-937649/v1
– volume: 274
  start-page: 330
  issue: 1
  year: 2016
  ident: 5424_CR22
  publication-title: Immunol Rev
  doi: 10.1111/imr.12499
– volume: 49
  start-page: 2079
  issue: 4
  year: 2021
  ident: 5424_CR36
  publication-title: Annals Stat
  doi: 10.1214/20-AOS2027
– volume: 12
  start-page: 740359
  year: 2021
  ident: 5424_CR30
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.740359
– ident: 5424_CR16
  doi: 10.1155/2020/4370983
– volume: 11
  start-page: 1011
  issue: 7
  year: 2021
  ident: 5424_CR8
  publication-title: Biomolecules
  doi: 10.3390/biom11071011
– volume: 361
  start-page: 21
  year: 2021
  ident: 5424_CR18
  publication-title: Int Rev Cell Mol Biology
  doi: 10.1016/bs.ircmb.2020.10.005
– volume: 76
  start-page: 16
  issue: 1
  year: 2012
  ident: 5424_CR10
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.05015-11
– volume: 80
  start-page: 501
  issue: 3
  year: 2020
  ident: 5424_CR15
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2020.09.029
– volume: 8
  start-page: 670
  issue: 9
  year: 2024
  ident: 5424_CR6
  publication-title: Lancet Child Adolesc Health
  doi: 10.1016/S2352-4642(24)00140-8
– ident: 5424_CR19
– volume: 9
  start-page: 465
  issue: 1
  year: 2023
  ident: 5424_CR1
  publication-title: Cell Death Discovery
  doi: 10.1038/s41420-023-01766-7
– volume: 46
  start-page: 10
  year: 2020
  ident: 5424_CR3
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-019-05878-6
– volume: 5
  start-page: 179
  issue: 1
  year: 2014
  ident: 5424_CR4
  publication-title: Virulence
  doi: 10.4161/viru.27045
– volume: 89
  start-page: 107087
  year: 2020
  ident: 5424_CR9
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.107087
– volume: 157
  start-page: 285
  issue: 5
  year: 2015
  ident: 5424_CR20
  publication-title: J Biochem
  doi: 10.1093/jb/mvv029
– volume: 9
  start-page: 2147
  year: 2018
  ident: 5424_CR5
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02147
– volume: 1214
  start-page: 18
  issue: 1
  year: 2010
  ident: 5424_CR11
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2010.05834.x
– ident: 5424_CR25
  doi: 10.3389/fimmu.2023.1325020
– volume: 49
  start-page: e1063
  issue: 11
  year: 2021
  ident: 5424_CR2
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000005337
– volume: 282
  start-page: 3438
  issue: 17
  year: 2015
  ident: 5424_CR23
  publication-title: FEBS J
  doi: 10.1111/febs.13353
– volume: 77
  start-page: ftz055
  issue: 6
  year: 2019
  ident: 5424_CR38
  publication-title: Pathogens Disease
  doi: 10.1093/femspd/ftz055
– volume: 10
  start-page: 787
  issue: 14
  year: 2022
  ident: 5424_CR17
  publication-title: Ann Transl Med
  doi: 10.21037/atm-22-3307
SSID ssj0017846
Score 2.3891728
Snippet This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian Randomization...
Objective This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian...
ObjectiveThis study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including Mendelian...
Abstract Objective This study aims to explore the genetic characteristics of pediatric sepsis through a combined analysis of multiple methods, including...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 66
SubjectTerms Analysis
ATP9A
Biomarkers
Child
Child, Preschool
Datasets
DEAD-box RNA Helicases - genetics
Demographic aspects
Differential expression analysis
Female
Gene expression
Genetic aspects
Genetic markers
Genetic Predisposition to Disease
Genomes
Genomics
GTPase-Activating Proteins - genetics
Humans
Immune response
Immune system
Infections
Inflammation
Influence
Male
MAP3K7CL
Mendelian Randomization
Mendelian Randomization Analysis
Mitochondrial Proton-Translocating ATPases - genetics
Pathogens
Pathophysiology
Pediatric sepsis
Pediatrics
Polymorphism, Single Nucleotide
RGL4
Risk factors
Sepsis
Sepsis - genetics
Sepsis - immunology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbtQw0EI9IC6IN4ECRkLiwEaN7cR2uIWWUmAXVWiR9mY5zljdA8mq2T30G_jpjvNYbcSBC9fMOInn4ZmxPTOEvNPaKoR5VCQOGKDkIta6TGOXsMprUMiYkOC8-CEvfqXfVtnqoNVXuBPWlwfuCXcCKdhSeWUTjBQqKTVkmuc8K5nNZam7Ytto88Zgajg_UGhWxxQZLU9aXIVRmULrVnRReBrfTMxQV63_7zX5wChNL0weWKDzB-T-4DrSov_lh-QO1I_I3cVwOP6Y_Pk6lH5AUtPG00XY3Q67GPSnravm95BxSbcNhe7mHVD0_ihKUEhkpOuxXUkbBm_GFh60hU27bj9SS33jdgjE932ZpzNaLC_zYkYXxaX4rk7nM4pfoWdnK8bm_AlZnn9enl7EQ6-F2GWp3MYOJNcuqaxW1lqQzmYVz50HD7lP8soJnzJbpVChQ6kEPoaEeRC59pWXVjwlR3VTw3NCXQ6ZdNILnSHDgFtfos_BvRdlUoLNIvJhpLzZ9BU1TBeJaGl6Phnkk-n4ZG4i8ikwZ48ZqmF3D1BGzCAj5l8yEpE3gbWmTy3d67QpQt5uyDQWEXnfYQStRg47OyQn4JRCfawJ5vEEE7XRTcGj-JhhNWiN4MEzxcAOJ_92Dw4jww23Gpod4jAZat_jChmRZ7207SeNVFYMfbGI6IkcTqgyhdTrq65WeDiTRwVkL_4HHV-Se7zTIRZzdUyOttc7eIU-2bZ83anfLQ1vM2c
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dj9MwDI-OQ0K8IL4pHBAkJB5YoU3bJEVCqNxxHLCiE9pJe4vS1IFJ0I51k9jfwD-N049xFSdea6dbYv9iu4ltQp5KqQXSLAKJAQYoaeRLWcS-CcLSShAoGJfgnH_mJ2fxx3ky3yNDu6N-AZsLQzvXT-ps9f3Fr5_bNwj41y3gJX_Z4B6LUHGNWdEBYbG_vUQuo2USrqNBHv89VRBobIfEmQvHjYxTW8P_3536nKkaX6M8Z5eOr5NrvUNJs04DbpA9qG6SK3l_ZH6L_P7QF4RAAdDa0tx983bfNugXXZX1jz4Pk65rCu19PKDoE1LUK5feSBdDE5PGDV4OjT1oA8tm0byimtrabJCI73s_jSc0m52m2YTm2Wn0SRxOJxR_hR4dzcNwym6T2fG72eGJ33dg8E0S87VvgDNpglJLobUGbnRSstRYsJDaIC1NZONQlzGU6GaKCB9DEFqIUmlLy3V0h-xXdQX3CDUpJNxwG8mExSUwbQv0RJi1UREUoBOPPB9WXi27OhuqjU8kV52cFMpJtXJSW4-8dcLZcboa2e2DevVV9ZBTEIMuhBU6wBiz5FxCIlnKkiLUKS8k98hjJ1rVJZzukK4yl83r8o8jjzxrOZz2oYSN7lMWcEquataI82DEiRg1Y_KgPmpQcRUx569iuIeTf7Iju5Hu3lsF9QZ5Qu4q4uO-6ZG7nbbtJo2rLEL00DwiR3o4WpUxpVp8ayuIu5N6hGV4____6wG5ylp0hD4TB2R_vdrAQ_TB1sWjFlh_AJMmLoI
  priority: 102
  providerName: Scholars Portal
Title Integration of Mendelian Randomization to explore the genetic influences of pediatric sepsis: a focus on RGL4, ATP9A, MAP3K7CL, and DDX11L2
URI https://www.ncbi.nlm.nih.gov/pubmed/39871218
https://www.proquest.com/docview/3201557685
https://www.proquest.com/docview/3160461101
https://pubmed.ncbi.nlm.nih.gov/PMC11770931
https://doaj.org/article/e4eab7f7a0924d668e582925b1a96b86
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LjtMw0IJdCXFBvAksxUhIHGi0sZM4DhfU7oMF2lVVFaniYjmODT2QlE172G_gp5lJnbIREpccMpOHPU-PPTOEvJFSZwBzIEjcwgIlj0MpiyQ0ESudtBkQBhOcp5fi4mvyeZkufcCt8ccqO53YKuqyNhgjP445WndwjtMP618hdo3C3VXfQuM2OcTSZcjV2XK_4GIZGNcuUUaK4wZ0MYgUNnAFR4Un4XXPGLU1-__VzDdMU__Y5A07dH6f3PMOJB3tKP6A3LLVQ3Jn6rfIH5Hfn3wBCJhwWjs6xRg3xjLoXFdl_dPnXdJNTW17_s5S8AEp8BGmM9JV17SkwYfXXSMP2th1s2reU01dbbYAhPd9nCRDOlrM8tGQTkez-Et2MhlS-Ao9PV0yNuGPyeL8bHFyEfqOC6FJE7EJjRVcmqjUMtNaW2F0WvLcOOts7qK8NLFLmC4TW4JbmcVw20bM2TiXrnRCx0_IQVVX9hmhJrepMMLFMuVJabl2BXge3Lm4iAqr04C862ZerXd1NVS7HpFC7eikgE6qpZO6DsgYibPHxJrY7Y366rvyIqZsYnWRuUxHsKYshZA2lTznacF0LgopAvIKSat2CaZ7yVYjzN7FfOM4IG9bDJRtoLDRPkUBhoRVsnqYRz1MkEnTB3fso7xOaNRfDg7I6z0Yn8RzbpWtt4DDBFbABz0ZkKc7btsPGmY5Y-CRBUT2-LA3K31ItfrRVgzHnXkQQ_b8___1gtzlrXSwkGdH5GBztbUvwefaFINWsAbkcHx2OZsP2sgFXKeJhOt8_O0Pxv8vhw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkIAXxJ3AYEYC8UCjJU7iOEgIhZXR0naaUCf1zXIcG_pAUpZWqL-B38J_5JxcyiIk3vaa46SNv3N1zoWQl0KoGGgWBIkZCFCSwBUiC13t-bkVJgZgsMB5dspH5-HnRbTYI7-7WhhMq-x0Yq2o81LjGflRwNC6g3McvV_9cHFqFH5d7UZoNGwxMdufELJV78ZDwPcVYycf58cjt50q4Ooo5GtXG86E9nIlYqWU4VpFOUu0NdYk1ktyHdjQV3locnCd4gAuG8-3JkiEzS1XATz2GrkOdtfDWC9e7OI7PwZb3tXlCH5UgeoHCcZ5seAXsdDd9mxfPSLgX0NwyRL2szQvmb2TO-R266_StGGwu2TPFPfIjVn7Rf4--TVu-00AvrS0dIZH6nh0Qr-oIi-_t2WedF1SU6f7GQouJwW2xepJuuxmpFR486qbG0Irs6qW1VuqqC31BojwvE_TcEDT-VmSDugsPQsm8fF0QOFX6HC48P0pe0DmVwHFQ7JflIV5TKhOTMQ1t4GIWJgbpmwGjg6zNsi8zKjIIW-6nZerpo2HrMMfwWWDkwScZI2T3DrkA4KzW4ktuOsL5cVX2Uq0NKFRWWxj5UEIm3MuTCRYwqLMVwnPBHfIIUIrm3rWnSKRKRYLY3lz4JDX9QpUJYCwVm1FBLwSNuXqrTzorQQVoPvkjn1kq4Iq-VdgHPJiR8Y7Ma2uMOUG1vgcG-6DWnbIo4bbdi8Nuxz74AA6RPT4sLcrfUqx_FY3KMdEAJB6_8n__9chuTmaz6ZyOj6dPCW3WC0pvsviA7K_vtiYZ-DurbPntZBRIq9YqP8AydprlA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integration+of+Mendelian+Randomization+to+explore+the+genetic+influences+of+pediatric+sepsis%3A+a+focus+on+RGL4%2C+ATP9A%2C+MAP3K7CL%2C+and+DDX11L2&rft.jtitle=BMC+pediatrics&rft.au=Zhang%2C+Liuzhao&rft.au=Chu%2C+Quanwang&rft.au=Jiang%2C+Shuyue&rft.au=Shao%2C+Bo&rft.date=2025-01-27&rft.pub=BioMed+Central&rft.eissn=1471-2431&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12887-025-05424-y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2431&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2431&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2431&client=summon